MDNA Life Sciences Inc. (MDLS)
MDNA Life Sciences will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$5.00 - $6.00
Shares Offered
2,454,545
Deal Size
$13.50M
MDNA Life Sciences Revenue
In the fiscal year ending September 30, 2021, MDNA Life Sciences had annual revenue of $3.60M with 3,298.10% growth.
Revenue (ttm)
$3.60M
Revenue Growth
+3,298.10%
P/S Ratio
14.42
Revenue / Employee
$240,153
Employees
15
Market Cap
51.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2021 | 3.60M | 3.50M | 3,298.10% |
| Sep 30, 2020 | 106.01K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMDLS News
- 3 years ago - IPO Update: MDNA Life Sciences Readies $10 Million IPO - Seeking Alpha
- 3 years ago - US IPO Weekly Recap: August Kicks off with a 2 IPO week - Renaissance Capital
- 3 years ago - MDNA Life Sciences IPO Registration Document (S-1) - SEC